Search results
Showing: 10 of 1257
Claim a refund for treatment costs
You can submit a claim for a refund if you have been charged for state-funded, medically necessary treatment whilst visiting:
an EU country
Norway
Iceland
Liechtenstein
Switzerland
We'll assess your claim to decide whether…
Pharmacy Quality Scheme 2023/2024 data published on the Open Data Portal
The NHSBSA data services team has used the open data portal to publish the latest 2023/24 Pharmacy Quality Scheme (PQS) data. This dataset is publicly available, and you can explore it on the open data portal website.
Part of the Community Pharmacy…
NHS Business Services Authority partners with two charities
Staff at the national NHS organisation, which is based in the North East, have chosen two charities to partner with this coming year, following their success in raising £67,000 for the British Heart Foundation during 2018/19.
The funds raised, well…
Summary of NHSBSA Board minutes - 16 October 2025
Meeting held at 9:00am in Stella House, Newcastle Upon Tyne. Present: Sue Douthwaite, ChairMichael Brodie, Chief ExecutiveKathy Gillatt, Non-Executive DirectorDavid Leather, Non-Executive DirectorMathew McKie, Non-Executive DirectorRandeep…
Pharmacy First June 2025
This is a news article on behalf of the Department of Health and Social Care
The clinical protocols and patient group directions (PGDs) for the NHS Pharmacy First service were updated in June 2025 to include some changes to the…
Prescription Cost Analysis - England 2019
Correction notice - a column was omitted from the presentation level tables of the latest release
Read our correction notices page for full details. Go to our Office for Statistics Regulation Assessment page to view their assessment of…
Rivaroxaban addition to Category A and M from September 2024
The addition of the following products into Category A:
Rivaroxaban 2.5mg tablets
Rivaroxaban 10mg tablets
The addition of the following products into Category M:
Rivaroxaban 15mg tablets
Rivaroxaban 20mg tablets
These additions are…
Drug Reimbursement – Azathioprine 50mg/5ml oral suspension
Since February 2024, a licensed version of Azathioprine 50mg/5ml oral suspension became available. Therefore, for prescriptions dispensed in February and March 2024:
where there is an endorsement for the licensed product, then reimbursement will…
Prescribing comparators
Access for:registered users via ePACT2public users via CatalystThe report shows potential savings that may be achieved by prescribing generically. The specialist drugs report is produced at national, ICB, commissioner / provider and…
Repeat dispensing report (including EPS items)
Access for:registered users via ePACT2public users via CatalystRepeat dispensing reports are a set of reports which provide information at both cost and item level.Report notesThere are 3 data views available, which are:…